About AVS Pulse
AVS Pulse is a company based in Ann Arbor (United States) founded in 2017 by Robert Chisena was acquired by Stryker in April 2026. AVS Pulse has raised $70.45 million across 5 funding rounds from investors including Stryker, BioStar Capital and Cue Growth Partners. AVS Pulse offers products and services including Pulse IVL. AVS Pulse operates in a competitive market with competitors including Silk Road Medical, Supira Medical, HDL Therapeutics, Lifetech Scientific Corporation and Shanghai Baixin'an Biotechnology, among others.
- Headquarter Ann Arbor, United States
- Founders Robert Chisena
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Avs Pulse, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AVS Pulse
AVS Pulse offers a comprehensive portfolio of products and services, including Pulse IVL.
Device that fractures arterial calcium using pulsatile waves to restore blood flow.
People of AVS Pulse
Unlock access to complete
Unlock access to complete
Funding Insights of AVS Pulse
AVS Pulse has successfully raised a total of $70.45M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $36 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AVS Pulse
AVS Pulse has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker, BioStar Capital and Cue Growth Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
3D-printed orthopedic products are manufactured for medical applications.
|
Locked | Locked | Locked |
Investor details for AVS Pulse
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AVS Pulse
Investment portfolio details for AVS Pulse
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AVS Pulse
Detailed financials for AVS Pulse
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avs Pulse Comparisons
Peer comparison for AVS Pulse
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AVS Pulse
AVS Pulse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, Supira Medical, HDL Therapeutics, Lifetech Scientific Corporation and Shanghai Baixin'an Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of neuroprotection devices for carotid artery disease
|
|
| Locked | Locked | Locked |
Developer of ventricular assist devices for coronary intervention and cardiogenic shock
|
|
| Locked | Locked | Locked |
Therapy to reverse coronary atherosclerosis is developed using patient plasma.
|
|
| Locked | Locked | Locked |
Interventional devices for cardiovascular and vascular diseases are developed.
|
|
| Locked | Locked | Locked |
A bioabsorbable coronary rapamycin-eluting stent system is developed using PLLA.
|
Detailed competitors of AVS Pulse
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avs Pulse
Complete news archive for AVS Pulse
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AVS Pulse
AVS Pulse was founded in 2017 and raised its 1st funding round 3 years after it was founded.
AVS Pulse is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Mark Toland is the current CEO of AVS Pulse.
AVS Pulse is a funded company, having raised a total of $70.45M across 5 funding rounds to date.
AVS Pulse was founded in 2017 in Ann Arbor, United States, as a medical device developer focused on cardiovascular interventions. The company creates the PULSE IVL System, a balloon-based platform that delivers pulsatile intravascular lithotripsy therapy. This approach targets severe calcium buildup in leg arteries to restore blood flow. Operations center on device innovation for peripheral artery disease management within the medtech sector.
AVS Pulse's top competitors include Silk Road Medical, Lifetech Scientific Corporation and InterShunt Technologies.
AVS Pulse offers Pulse IVL.
AVS Pulse has 3 investors. Key investors include Stryker, BioStar Capital, and Cue Growth Partners.